Concord Biotech Share Price
Know More₹2,177.20-55.65 (-2.49%)
17-Jan-2025₹2,178.00-62.75 (-2.80%)
17-Jan-2025BSE : 543960
NSE : CONCORDBIO
Sector : Health care
ISIN Code : INE338H01029
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 17-Jan-2025
| Market Cap (₹ Cr) | 22,774 |
Traded Value (₹ Cr) | 0.46 |
Volume (Shares) | 2,130 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,658.00 |
52-Week High Date | 20-Sep-2024 |
52-Week Low (₹) | 1,326.90 |
52-Week Low Date | 04-Jun-2024 |
All Time High (₹) | 2,658.00 |
All Time High Date | 20-Sep-2024 |
All Time Low (₹) | 900.00 |
All Time Low Date | 18-Aug-2023 |
Concord Biotech Ltd
Concord Biotech News
Concord Biotech Announcement
Concord Biotech Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 22,782 |
| EPS - TTM (₹) [C] | 31.35 |
| P/E Ratio (X) [C] | 69.47 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 875.00 |
| Latest Dividend Date | 21-Jun-2024 |
| Dividend Yield (%) | 0.40 |
| Book Value Share (₹) [C] | 152.02 |
| P/B Ratio (₹) [C] | 14.33 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HSBC Small Cap Fund (G) | 188.79 | 8,53,962 | 1.09 |
| HSBC Small Cap Fund (IDCW) | 188.79 | 8,53,962 | 1.09 |
| HSBC Small Cap Fund - Direct (G) | 188.79 | 8,53,962 | 1.09 |
| HSBC Small Cap Fund - Direct (IDCW) | 188.79 | 8,53,962 | 1.09 |
| DSP Healthcare Fund (G) | 129.10 | 5,83,966 | 3.87 |
| DSP Healthcare Fund (IDCW) | 129.10 | 5,83,966 | 3.87 |
| DSP Healthcare Fund - Direct (G) | 129.10 | 5,83,966 | 3.87 |
| DSP Healthcare Fund - Direct (IDCW) | 129.10 | 5,83,966 | 3.87 |
| Invesco India Multicap Fund (G) | 77.50 | 3,50,565 | 1.95 |
| Invesco India Multicap Fund (IDCW) | 77.50 | 3,50,565 | 1.95 |
Load more
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 2,173.80 2,254.75 |
| Week Low/High (₹) | 2,173.80 2,359.00 |
| Month Low/High (₹) | 2,035.50 2,401.00 |
| Year Low/High (₹) | 1,327.05 2,664.00 |
| All time Low/High (₹) | 900.00 2,664.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -3.43% | -3.48% | -0.98 | -0.97% |
| 1 Month | 5.92% | 5.77% | -5.04 | -4.65% |
| 3 Month | 7.98% | 7.88% | -5.42 | -6.25% |
| 6 Month | 28.02% | 27.98% | -5.08 | -5.73% |
| 1 Year | 57.00% | 56.93% | 7.16 | 7.56% |
| 3 Year | % | % | 24.97 | 26.74% |
Company Info
Company Information
Chairman & Managing Director : SUDHIR JAIRAM VAID
Joint Managing Director & CEO : ANKUR VAID
Non Executive Director : Ravi Kapoor
Nominee : Rajiv Agarwal
Independent Director : BHARTI KHANNA
Independent Director : Amitabh Thakore
Independent Director : Arvind Agarwal
Independent Director : Jayaram Easwaran
Independent Director : Mandayam Chakravarthy Sriraman
Assistant VP (Finance) & CS : S Prakash
Registered Office: 1482-86 Trasad Road, Dholka,Ahmedabad,Gujarat-382225 Ph: 91-079-68138700
FAQs about Concord Biotech Ltd
1. What's the Concord Biotech Ltd share price today?
Concord Biotech Ltd share price was Rs 2,177.20 at close on 17th Jan 2025. Concord Biotech Ltd share price was down by 2.49% from the previous closing price of Rs 2,232.85. Concord Biotech Ltd share price trend:
- Last 1 Month: Concord Biotech Ltd share price moved up by 5.92% on BSE
- Last 3 Months: Concord Biotech Ltd share price moved up by 7.98% on BSE
- Last 12 Months: Concord Biotech Ltd share price moved up by 57.00% on BSE
- Last 3 Years: Concord Biotech Ltd price moved up by % on BSE
2. How can I quickly analyse the performance of the Concord Biotech Ltd stock?
The performance of the Concord Biotech Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 69.47
- Price to book value ratio is 14.33
- Dividend yield of 0.40
- The EPS (trailing 12 months) of the Concord Biotech Ltd stock is Rs 31.35
3. What is the market cap of Concord Biotech Ltd?
Concord Biotech Ltd has a market capitalisation of Rs 22,774 crore.
4. What is Concord Biotech Ltd's 52-week high/low share price?
The Concord Biotech Ltd’s 52-week high share price is Rs 2,658.00 and 52-week low share price is Rs 1,326.90.
5. Is the Concord Biotech Ltd profitable?
On a consolidated basis, Concord Biotech Ltd reported a profit of Rs 98.70 crore on a total income of Rs 320.21 crore for the quarter ended 2024. For the year ended Sep 2024, Concord Biotech Ltd had posted a profit of Rs 95.74 crore on a total income of Rs 320.21 crore.
6. Which are Concord Biotech Ltd’s peers in the Health care sector?
Concord Biotech Ltd’s top 5 peers in the Health care sector are J B Chemicals &, Emcure Pharma, Wockhardt, Concord Biotech, Pfizer, Natco Pharma, Alembic Pharma.
7. Who owns how much in Concord Biotech Ltd?
Key changes to the Concord Biotech Ltd shareholding are as follows:
- Promoter holding in Concord Biotech Ltd has gone up to 44.08 per cent as of Sep 2024 from 44.08 per cent as of Dec 2023.
